102 related articles for article (PubMed ID: 30654815)
1. The prolonged interval between induction chemotherapy and radiotherapy is associated with poor prognosis in patients with nasopharyngeal carcinoma.
Peng L; Liu JQ; Xu C; Huang XD; Tang LL; Chen YP; Sun Y; Ma J
Radiat Oncol; 2019 Jan; 14(1):9. PubMed ID: 30654815
[TBL] [Abstract][Full Text] [Related]
2. An open-label, single-arm phase II clinical study of induction chemotherapy and sequential Nimotuzumab combined with concurrent chemoradiotherapy in N3M0 stage nasopharyngeal carcinoma.
Zhang S; Huang X; Zhou L; Wu G; Lin J; Yang S; Chen J; Lin S
J BUON; 2018; 23(6):1656-1661. PubMed ID: 30610791
[TBL] [Abstract][Full Text] [Related]
3. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
[TBL] [Abstract][Full Text] [Related]
4. Induction chemotherapy followed by concurrent chemoradiotherapy vs. concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
Zhang J; Chen S; Li G; Zhang W; Qin T; Yin P; Huang H; Jiang H
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1087-1097. PubMed ID: 28429051
[TBL] [Abstract][Full Text] [Related]
5. The Tumour Response to Induction Chemotherapy has Prognostic Value for Long-Term Survival Outcomes after Intensity-Modulated Radiation Therapy in Nasopharyngeal Carcinoma.
Peng H; Chen L; Zhang Y; Li WF; Mao YP; Liu X; Zhang F; Guo R; Liu LZ; Tian L; Lin AH; Sun Y; Ma J
Sci Rep; 2016 Apr; 6():24835. PubMed ID: 27099096
[TBL] [Abstract][Full Text] [Related]
6. The results and prognosis of different treatment modalities for solitary metastatic lung tumor from nasopharyngeal carcinoma: a retrospective study of 105 cases.
Ma J; Wen ZS; Lin P; Wang X; Xie FY
Chin J Cancer; 2010 Sep; 29(9):787-95. PubMed ID: 20800020
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Childhood Nasopharyngeal Carcinoma With Induction Chemotherapy and Concurrent Chemoradiotherapy: Results of the Children's Oncology Group ARAR0331 Study.
Rodriguez-Galindo C; Krailo MD; Krasin MJ; Huang L; McCarville MB; Hicks J; Pashankar F; Pappo AS
J Clin Oncol; 2019 Dec; 37(35):3369-3376. PubMed ID: 31553639
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus radiotherapy for locoregionally advanced nasopharyngeal carcinoma.
Huang PY; Cao KJ; Guo X; Mo HY; Guo L; Xiang YQ; Deng MQ; Qiu F; Cao SM; Guo Y; Zhang L; Li NW; Sun R; Chen QY; Luo DH; Hua YJ; Mai HQ; Hong MH
Oral Oncol; 2012 Oct; 48(10):1038-1044. PubMed ID: 22591726
[TBL] [Abstract][Full Text] [Related]
9. A novel scoring model to predict benefit of additional induction chemotherapy to concurrent chemoradiotherapy in stage II-IVa nasopharyngeal carcinoma.
Peng L; Chen YP; Xu C; Tang LL; Chen L; Lin AH; Liu X; Sun Y; Ma J
Oral Oncol; 2018 Nov; 86():258-265. PubMed ID: 30409310
[TBL] [Abstract][Full Text] [Related]
10. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.
Chen QY; Wen YF; Guo L; Liu H; Huang PY; Mo HY; Li NW; Xiang YQ; Luo DH; Qiu F; Sun R; Deng MQ; Chen MY; Hua YJ; Guo X; Cao KJ; Hong MH; Qian CN; Mai HQ
J Natl Cancer Inst; 2011 Dec; 103(23):1761-70. PubMed ID: 22056739
[TBL] [Abstract][Full Text] [Related]
11. The impact of smoking on the clinical outcome of locoregionally advanced nasopharyngeal carcinoma after chemoradiotherapy.
Guo SS; Huang PY; Chen QY; Liu H; Tang LQ; Zhang L; Liu LT; Cao KJ; Guo L; Mo HY; Guo X; Hong MH; Mai HQ
Radiat Oncol; 2014 Nov; 9():246. PubMed ID: 25424191
[TBL] [Abstract][Full Text] [Related]
12. The impact of the interval between the induction of chemotherapy and radiotherapy on the survival of patients with nasopharyngeal carcinoma.
Yang S; Fu X; Huang G; Chen J; Luo S; Wang Z; Kong F; Wu G; Lin S; Wang F; Chen L
Cancer Manag Res; 2019; 11():2313-2320. PubMed ID: 30962719
[TBL] [Abstract][Full Text] [Related]
13. The prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma.
Lee CC; Chu ST; Chou P; Lee CC; Chen LF
Clin Otolaryngol; 2008 Oct; 33(5):442-9. PubMed ID: 18983377
[TBL] [Abstract][Full Text] [Related]
14. Investigation of long-term survival outcomes and failure patterns of patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: a retrospective analysis.
Zhao W; Lei H; Zhu X; Li L; Qu S; Liang X
Oncotarget; 2016 Dec; 7(52):86914-86925. PubMed ID: 27894100
[TBL] [Abstract][Full Text] [Related]
15. Treatment results of 59 young patients with nasopharyngeal carcinoma.
Selek U; Ozyar E; Ozyigit G; Varan A; Buyukpamukcu M; Atahan IL
Int J Pediatr Otorhinolaryngol; 2005 Feb; 69(2):201-7. PubMed ID: 15656953
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.
Chua DT; Wei WI; Sham JS; Cheng AC; Au G
Head Neck; 2003 Jul; 25(7):585-94. PubMed ID: 12808662
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome and morbidity in pediatric patients with nasopharyngeal cancer treated with chemoradiotherapy.
Sahai P; Mohanti BK; Sharma A; Thakar A; Bhasker S; Kakkar A; Sharma MC; Upadhyay AD
Pediatr Blood Cancer; 2017 Feb; 64(2):259-266. PubMed ID: 27681956
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
He YX; Wang Y; Cao PF; Shen L; Zhao YJ; Zhang ZJ; Chen DM; Yang TB; Huang XQ; Qin Z; Dai YY; Shen LF
Chin J Cancer; 2016 Nov; 35(1):96. PubMed ID: 27852284
[TBL] [Abstract][Full Text] [Related]
20. Combined high-dose radiation therapy and systemic chemotherapy improves survival in patients with newly diagnosed metastatic nasopharyngeal cancer.
Lin S; Tham IW; Pan J; Han L; Chen Q; Lu JJ
Am J Clin Oncol; 2012 Oct; 35(5):474-9. PubMed ID: 21577086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
